RCMI Coordinating Center (RCMI CC) Header Logo

Guangdi Wang

Concepts (297)

Back to Profile
Concepts are derived automatically from a person's publications.
The timeline below shows the dates (blue tick marks) of publications associated with Guangdi Wang's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that Guangdi Wang has written about over time.
Morpholines, 3 publications between 2002 and 2010, average publication date January 2006. Microsomes, Liver, 6 publications between 2002 and 2013, average publication date January 2007. Receptor, Cannabinoid, CB2, 2 publications between 2006 and 2010, average publication date July 2008. Estrogens, 2 publications between 2010 and 2013, average publication date January 2012. Estrogen Antagonists, 2 publications between 2010 and 2013, average publication date January 2012. Proteomics, 6 publications between 2008 and 2013, average publication date March 2012. Drug Resistance, Neoplasm, 6 publications between 2008 and 2016, average publication date January 2013. Structure-Activity Relationship, 8 publications between 2002 and 2015, average publication date February 2013. Prodrugs, 4 publications between 2007 and 2015, average publication date February 2013. Receptors, Estrogen, 4 publications between 2012 and 2014, average publication date April 2013. Antineoplastic Agents, Hormonal, 3 publications between 2012 and 2015, average publication date September 2013. Breast Neoplasms, 12 publications between 2008 and 2020, average publication date October 2013. Tamoxifen, 6 publications between 2012 and 2016, average publication date May 2014. Cell Line, Tumor, 14 publications between 2010 and 2020, average publication date September 2014. Antineoplastic Agents, 13 publications between 2010 and 2019, average publication date October 2014. Drug Design, 8 publications between 2013 and 2017, average publication date February 2015. Estrogen Receptor alpha, 3 publications between 2010 and 2020, average publication date October 2015. Neoplasms, 6 publications between 2013 and 2019, average publication date November 2015. Selective Estrogen Receptor Modulators, 2 publications between 2016 and 2020, average publication date May 2018.

To see the data from this visualization as text, click here.
Wang's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (297)
Explore
_
Co-Authors (14)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support